Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/007—Pulmonary tract; Aromatherapy
  • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
  • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/02—Inorganic compounds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
  • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/08—Solutions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/10—Dispersions; Emulsions
  • A61K9/12—Aerosols; Foams
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/02—Nasal agents, e.g. decongestants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/06—Antiasthmatics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
  • A61P11/08—Bronchodilators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/06—Antipsoriatics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P27/00—Drugs for disorders of the senses
  • A61P27/02—Ophthalmic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
  • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/08—Antiallergic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Organic Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Epidemiology (AREA)
• Pulmonology (AREA)
• Immunology (AREA)
• Dispersion Chemistry (AREA)
• Otolaryngology (AREA)
• Dermatology (AREA)
• Inorganic Chemistry (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Molecular Biology (AREA)
• Biochemistry (AREA)
• Urology & Nephrology (AREA)
• Heart & Thoracic Surgery (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Ophthalmology & Optometry (AREA)
• Rheumatology (AREA)
• Pain & Pain Management (AREA)
• Biomedical Technology (AREA)
• Cardiology (AREA)
• Vascular Medicine (AREA)
• Transplantation (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicinal Preparation (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=54196992

Family Applications (1)

Country Status (27)

Families Citing this family (14)

Family Cites Families (19)

• 2015
  • 2015-09-15 ES ES15770593.0T patent/ES2670025T3/es active Active
  • 2015-09-15 SI SI201530213T patent/SI3193835T1/en unknown
  • 2015-09-15 EP EP17207623.4A patent/EP3332767B1/en active Active
  • 2015-09-15 HU HUE19152629A patent/HUE055527T2/hu unknown
  • 2015-09-15 PL PL19152629T patent/PL3494962T3/pl unknown
  • 2015-09-15 CN CN202010090019.5A patent/CN111249260B/zh active Active
  • 2015-09-15 PT PT17207623T patent/PT3332767T/pt unknown
  • 2015-09-15 HU HUE17207623A patent/HUE045303T2/hu unknown
  • 2015-09-15 MX MX2017003102A patent/MX2017003102A/es active IP Right Grant
  • 2015-09-15 PT PT191526292T patent/PT3494962T/pt unknown
  • 2015-09-15 ES ES19152629T patent/ES2875584T3/es active Active
  • 2015-09-15 JP JP2017514346A patent/JP6860477B2/ja active Active
  • 2015-09-15 LT LTEP19152629.2T patent/LT3494962T/lt unknown
  • 2015-09-15 MY MYPI2017000391A patent/MY196072A/en unknown
  • 2015-09-15 NZ NZ767295A patent/NZ767295A/en unknown
  • 2015-09-15 DK DK15770593.0T patent/DK3193835T3/en active
  • 2015-09-15 LT LTEP17207623.4T patent/LT3332767T/lt unknown
  • 2015-09-15 PL PL15770593T patent/PL3193835T3/pl unknown
  • 2015-09-15 DK DK19152629.2T patent/DK3494962T3/da active
  • 2015-09-15 PL PL17207623T patent/PL3332767T3/pl unknown
  • 2015-09-15 US US15/509,943 patent/US9956171B2/en active Active
  • 2015-09-15 SI SI201531657T patent/SI3494962T1/sl unknown
  • 2015-09-15 NO NO15770593A patent/NO3193835T3/no unknown
  • 2015-09-15 NZ NZ729796A patent/NZ729796A/en unknown
  • 2015-09-15 AU AU2015316592A patent/AU2015316592B2/en active Active
  • 2015-09-15 DK DK17207623.4T patent/DK3332767T3/da active
  • 2015-09-15 EP EP19152629.2A patent/EP3494962B1/en active Active
  • 2015-09-15 RU RU2017108432A patent/RU2699995C2/ru active
  • 2015-09-15 HU HUE15770593A patent/HUE038433T2/hu unknown
  • 2015-09-15 EP EP15770593.0A patent/EP3193835B1/en active Active
  • 2015-09-15 RS RS20190765A patent/RS58897B1/sr unknown
  • 2015-09-15 LT LTEP15770593.0T patent/LT3193835T/lt unknown
  • 2015-09-15 WO PCT/GB2015/052668 patent/WO2016042313A1/en active Application Filing
  • 2015-09-15 RS RS20211044A patent/RS62252B1/sr unknown
  • 2015-09-15 CN CN201580053062.1A patent/CN106794157B/zh active Active
  • 2015-09-15 PT PT157705930T patent/PT3193835T/pt unknown
  • 2015-09-15 CA CA2959943A patent/CA2959943C/en active Active
  • 2015-09-15 ES ES17207623T patent/ES2730810T3/es active Active
  • 2015-09-15 CN CN201811561721.4A patent/CN110051627A/zh active Pending
  • 2015-09-15 KR KR1020177006862A patent/KR102379309B1/ko active IP Right Grant
  • 2015-09-15 SI SI201530774T patent/SI3332767T1/sl unknown
  • 2015-09-15 NZ NZ767296A patent/NZ767296A/en unknown
  • 2015-09-15 RS RS20180519A patent/RS57227B1/sr unknown
  • 2015-09-15 SG SG11201701854WA patent/SG11201701854WA/en unknown
• 2017
  • 2017-03-02 IL IL250895A patent/IL250895B/en active IP Right Grant
  • 2017-03-14 PH PH12017500479A patent/PH12017500479B1/en unknown
• 2018
  • 2018-03-21 US US15/927,517 patent/US10945950B2/en active Active
  • 2018-05-03 CY CY20181100455T patent/CY1120264T1/el unknown
  • 2018-05-25 HR HRP20180833TT patent/HRP20180833T1/hr unknown
  • 2018-07-10 HK HK18108909.3A patent/HK1249415B/zh unknown
  • 2018-12-20 JP JP2018238014A patent/JP6795574B2/ja active Active
  • 2018-12-24 AU AU2018286571A patent/AU2018286571B2/en active Active
• 2019
  • 2019-06-18 CY CY20191100622T patent/CY1121698T1/el unknown
  • 2019-06-19 HR HRP20191122TT patent/HRP20191122T1/hr unknown
• 2020
  • 2020-05-11 AU AU2020203081A patent/AU2020203081B2/en active Active
• 2021
  • 2021-06-30 HR HRP20211035TT patent/HRP20211035T1/hr unknown
  • 2021-08-10 CY CY20211100720T patent/CY1124546T1/el unknown

Also Published As

Similar Documents